Skip to main content

Suboptimal Health Status and Cardiovascular Deficits

  • Chapter
  • First Online:
Flammer Syndrome

Part of the book series: Advances in Predictive, Preventive and Personalised Medicine ((APPPM,volume 11))

Abstract

Suboptimal Health Status (SHS) is the subclinical, reversible stage of pre-chronic disease. It is the physical state between health and disease, characterised by the perception of health complaints, general weakness, chronic fatigue and low energy levels. We have developed a tool to measure SHS, Suboptimal Health Status Questionnaire-25 (SHSQ-25) which assesses five components of health: (1) fatigue, (2) the cardiovascular system, (3) the digestive tract, (4) the immune system, and (5) mental status. To date, the SHSQ-25 as a self-reported survey instrument has been validated in various populations, including African, Chinese and Caucasians, therefore generating an unprecedented opportunity for the early detection of chronic health conditions, namely, cardiovascular diseases and diabetes. Our studies suggest that SHS is associated with the major components of cardiovascular health. We investigated the association between SHS and cardiovascular health metrics (defined by American Heart Association) among Chinese. Participants in the largest quartile of ideal cardiovascular health (CVH) metrics showed a lower likelihood of having on optimal SHS score compared to those in the smallest quartile after adjusting for socio-demographic factors (age, gender, marital status, alcohol consumption, income level and education). Four metrics (smoking, physical inactivity, poor dietary intake and ideal control of blood pressure) were significantly correlated with the risk of SHS. The study indicated that ideal CVH metrics were associated with a lower prevalence of SHS, and the combined evaluation of SHS and CVH metrics allows the risk classification of cardiovascular disease, consequently contributing to the prevention of cardiovascular diseases from a preventive, predicative and personalised medicine perspective (PPPM).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Wang W, Russell A, Yan Y (2014) Traditional Chinese medicine and new concepts of predictive, preventive and personalized medicine in diagnosis and treatment of suboptimal health. Global Health Epidemiology Reference Group (GHERG). EPMA J 5(1):4. https://doi.org/10.1186/1878-5085-5-4

    Article  PubMed  PubMed Central  Google Scholar 

  2. Yan YX, Liu YQ, Li M, Hu PF, Guo AM, Yang XH, et al (2009) Development and evaluation of a questionnaire for measuring suboptimal health status in urban Chinese. J Epidemiol 19(6):333–341

    Article  Google Scholar 

  3. Adua E, Roberts P, Wang W (2017) Incorporation of suboptimal health status as a potential risk assessment for type II diabetes mellitus: a case-control study in a Ghanaian population. EPMA J 8(4):345–355

    Article  Google Scholar 

  4. Alzain MA, Asweto CO, Zhang J, Fang H, Zhao Z, Guo X, et al (2017) Telomere length and accelerated biological aging in the China suboptimal health cohort: a case-control study. OMICS 21(6):333–339

    Article  CAS  Google Scholar 

  5. Kupaev V, Borisov O, Marutina E, Yan YX, Wang W (2016) Integration of suboptimal health status and endothelial dysfunction as a new aspect for risk evaluation of cardiovascular disease. EPMA J 7(1):19. https://doi.org/10.1186/s13167-016-0068-0

    Article  PubMed  PubMed Central  Google Scholar 

  6. Wang W, Yan Y (2012) Suboptimal health: a new health dimension for translational medicine. Clin Trans Med 1(1):28

    Article  Google Scholar 

  7. Wang Y, Ge S, Yan Y, Wang A, Zhao Z, Yu X, et al (2016) China suboptimal health cohort study: rationale, design and baseline characteristics. J Transl Med 14(1):291

    Google Scholar 

  8. Wang Y, Liu X, Qiu J, Wang H, Liu D, Zhao Z, et al (2017) Association between ideal cardiovascular health metrics and suboptimal health status in Chinese population. Sci Rep 7(1):14975

    Google Scholar 

  9. Yan YX, Dong J, Liu YQ, Yang XH, Li M, Shia G, Wang W (2012) Association of suboptimal health status and cardiovascular risk factors in urban Chinese workers. J Urban Health 89(2):329–338

    Article  Google Scholar 

  10. Yan YX, Wu LJ, Xiao HB, Wang S, Dong J, Wang W (2018) Latent class analysis to evaluate performance of plasma cortisol, plasma catecholamines, and SHSQ-25 for early recognition of suboptimal health status. EPMA J. https://doi.org/10.1007/s13167-018-0144-8

    Article  Google Scholar 

  11. Bermingham SL, Cohen A, Hague J, Parsonage M (2010) The cost of somatisation among the working-age population in England for the year 2008–2009. Ment Health Fam Med 7:71–84

    PubMed  PubMed Central  Google Scholar 

  12. Hou HF, Feng X, Li Y, Meng Z, Guo D, Wang F, et al (2018) Suboptimal health status and psychological symptoms among Chinese college students: a perspective of predictive, preventive and personalised heath. EPMA J. https://doi.org/10.1007/s13167-018-0148-413

  13. Bi J, Huang Y, Xiao Y, Cheng J, Li F, Wang T, et al (2014) Association of lifestyle factors and suboptimal health status: a cross-sectional study of Chinese students. BMJ Open 4(6):e005156

    Article  Google Scholar 

  14. Chen J, Cheng J, Liu Y, Tang Y, Sun X, Wang T, et al (2014) Associations between breakfast eating habits and health-promoting lifestyle, suboptimal health status in Southern China: a population based, cross sectional study. J Transl Med 12:348

    Google Scholar 

  15. Wu S, Xuan Z, Li F, Xiao W, Fu X, Jiang P, et al (2016) Work-recreation balance, health-promoting lifestyles and suboptimal health status in Southern China: a cross-sectional study. Int J Environ Res Public Health 13(3):E339

    Article  Google Scholar 

  16. Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, et al (2010) Defining and setting national goals for cardiovascular health promotion and disease reduction: the american heart association’s strategic impact goal through 2020 and beyond. Circulation 121:586–613

    Article  Google Scholar 

  17. Chiuve SE, McCullough ML, Sacks FM, Rimm EB (2006) Healthy lifestyle factors in the primary prevention of coronary heart disease among men: benefits among users and nonusers of lipid-lowering and antihypertensive medications. Circulation 114:160–167

    Article  Google Scholar 

  18. Ford ES, Greenlund KJ, Hong Y (2012) Ideal cardiovascular health and mortality from all causes and diseases of the circulatory system among adults in the united states. Circulation 125:987–995

    Article  Google Scholar 

  19. Yan N, Zhou Y, Wang Y, Wang A, Yang X, Russell A, et al (2016) Association of ideal cardiovascular health and brachial-ankle pulse wave velocity: a cross-sectional study in Northern China. J Stroke Cerebrovasc Dis 25(1):41–48

    Article  Google Scholar 

  20. Zhang N, Yang Y, Wang A, Cao Y, Li J, Yang Y, et al (2016) Association of ideal cardiovascular health metrics and cognitive functioning: the APAC study. Eur J Neurol 23(9):1447–1454

    Article  CAS  Google Scholar 

  21. Lemke HU, Golubnitschaja O (2014) Towards personal health care with model-guided medicine: long-term PPPM-related strategies and realisation opportunities within ‘horizon 2020’. EPMA J 5(1):8

    Article  Google Scholar 

  22. Golubnitschaja O, Kinkorova J, Costigliola V (2014) Predictive, preventive and personalised medicine as the hardcore of ‘horizon 2020’: EPMA position paper. EPMA J 5(1):6

    Article  Google Scholar 

  23. Golubnitschaja O, Baban B, Boniolo G, Wang W, Bubnov R, Kapalla M et al (2016) Medicine in the early twenty-first century: paradigm and anticipation-EPMA position paper 2016. EPMA J 7(1):23

    Article  Google Scholar 

  24. Golubnitschaja O (2010) Time for new guidelines in advanced diabetes care: paradigm change from delayed interventional approach to predictive, preventive & personalized medicine. EPMA J 1(1):3–12

    Article  Google Scholar 

  25. Chen J, Xiang H, Jiang P, Yu L, Jing Y, Li F, et al (2017) The role of healthy lifestyle in the implementation of regressing suboptimal health status among college students in China: a nested case-control study. Int J Environ Res Public Health 14(3):E240

    Article  Google Scholar 

  26. Zhang X, Yao S, Sun G, Yu S, Sun Z, Zhong L, et al (2012) Total and abdominal obesity among rural Chinese women and the association with hypertension. Nutrition 28(1):46–52

    Article  Google Scholar 

  27. Saladini F, Benetti E, Fania C, Mos L, Casiglia E, Palatini P (2016) Effects of smoking on central blood pressure and pressure amplification in hypertension of the young. Vasc Med 21(5):422–428

    Article  Google Scholar 

  28. Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, Board on the Health of Select Populations, Institute of Medicine (2015) Beyond myalgic encephalomyelitis/chronic fatigue syndrome: redefining an illness. National Academies Press (US), Washington, DC

    Google Scholar 

  29. Wyller VB, Barbieri R, Saul JP (2011) Blood pressure variability and closed-loop baroreflex assessment in adolescent chronic fatiguesyndrome during supine rest and orthostatic stress. Eur J Appl Physiol 111(3):497–507

    Article  Google Scholar 

  30. Guariguata L, Whiting D, Hambleton I, Beagley J, Linnenkamp U, Shaw J (2014) Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 103(2):137–149

    Article  CAS  Google Scholar 

  31. Lindström J, Tuomilehto J (2003) The diabetes risk score. Diabetes Care 26(3):725–731

    Article  Google Scholar 

  32. Chen L, Magliano DJ, Zimmet PZ (2012) The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives. Nat Rev Endocrinol 8(4):228–236

    Article  CAS  Google Scholar 

  33. Rich PA, Shaefer CF, Parkin CG, Edelman SV (2013) Using a quantitative measure of diabetes risk in clinical practice to target and maximize diabetes prevention interventions. Clin Diabetes 31(2):82–89

    Article  Google Scholar 

  34. Bi Y, Wang T, Xu M, Xu Y, Li M, Lu J, et al (2012) Advanced research on risk factors of type 2 diabetes. Diabetes Metab Res Rev 28(s2):32–39

    Article  Google Scholar 

  35. Stumvoll M, Goldstein BJ, van Haeften TW (2005) Type 2 diabetes: principles of pathogenesis and therapy. Lancet 365(9467):1333–1346

    Article  CAS  Google Scholar 

  36. DeFronzo RA, Abdul-Ghani M (2011) Type 2 diabetes can be prevented with early pharmacological intervention. Diabetes Care 34(Supplement 2):S202–S2S9

    Article  Google Scholar 

  37. Deepa M, Anjana R, Mohan V (2017) Role of lifestyle factors in the epidemic of diabetes: lessons learnt from India. Eur J Clin Nutr 71(7):825–831

    Article  CAS  Google Scholar 

  38. Hulsegge G, Spijkerman A, van der Schouw Y, Bakker SJ, Gansevoort R, Smit H et al (2017) Trajectories of metabolic risk factors and biochemical markers prior to the onset of type 2 diabetes: the population-based longitudinal Doetinchem study. Nutr Diabetes 7(5):e270

    Article  CAS  Google Scholar 

  39. Zou X, Zhou X, Ji L, Yang W, Lu J, Weng J, et al (2017) The characteristics of newly diagnosed adult early-onset diabetes: a population based cross-sectional study. Sci Rep 7:46534

    Article  CAS  Google Scholar 

  40. Adua E, Roberts P, Sakyi SA, Yeboah FA, Dompreh A, Frimpong K, et al (2017) Profiling of cardio-metabolic risk factors and medication utilisation among type II diabetes patients in Ghana: a prospective cohort study. Clin Trans Med 6(1):32

    Article  Google Scholar 

  41. Echouffo-Tcheugui JB, Kengne AP, Erqou S, Cooper RS (2015) High blood pressure in sub-Saharan Africa: the urgent imperative for prevention and control. J Clin Hypertens 17(10):751–755

    Article  Google Scholar 

  42. Cappuccio FP, Miller MA (2016) Cardiovascular disease and hypertension in sub-Saharan Africa: burden, risk and interventions. Intern Emerg Med 11(3):299–305

    Article  Google Scholar 

  43. Ofori-Asenso R, Garcia D (2016) Cardiovascular diseases in Ghana within the context of globalization. Cardiovasc Diagn Ther 6(1):67–77

    PubMed  PubMed Central  Google Scholar 

  44. Mendis S, Puska P, Norrving B (2011) Global atlas on cardiovascular disease prevention and control. World Health Organization, Geneva, pp 1–55

    Google Scholar 

  45. Mensah G (2008) Ischaemic heart disease in Africa. Heart 94(7):836–843

    Article  CAS  Google Scholar 

  46. Khatibzadeh S, Farzadfar F, Oliver J, Ezzati M, Moran A (2013) Worldwide risk factors for heart failure: a systematic review and pooled analysis. Int J Cardiol 168(2):1186–1194

    Article  Google Scholar 

  47. Yu X, Wang Y, Kristic J, Dong J, Chu X, Ge S, et al (2016) Profiling IgG N-glycans as potential biomarker of chronological and biological ages: a community-based study in a Han Chinese population. Medicine (Baltimore) 95(28):e4112

    Article  CAS  Google Scholar 

  48. Franco OH, Karnik K, Osborne G, Ordovas JM, Catt M, van der Ouderaa F (2009) Changing course in ageing research: the healthy ageing phenotype. Maturitas 63(1):13–19

    Article  Google Scholar 

  49. Bonora E, Tuomilehto J (2011) The pros and cons of diagnosing diabetes with A1C. Diabetes Care 34(Suppl 2):S184–SS90

    Article  CAS  Google Scholar 

  50. Danquah I, Bedu-Addo G, Terpe KJ, Micah F, AmoakoYA AYA, et al (2012) Diabetes mellitus type 2 in urban Ghana: characteristics and associated factors. BMC Public Health 12(210):1–8

    Google Scholar 

  51. Kahn HS, Cheng YJ, Thompson TJ, Imperatore G, Gregg EW (2009) Two risk-scoring systems for predicting incident diabetes mellitus in US adults age 45 to 64 years. Ann Intern Med 150:741–751

    Article  Google Scholar 

  52. Kolberg JA, Jorgensen T, Gerwien RW, Hamren S, McKenna MP, Moler E, et al (2009) Development of a type 2 diabetes risk model from a panel of serum biomarkers from the Inter99 cohort. Diabetes Care 32:1207–1212

    Article  Google Scholar 

  53. Liu M, Pan C, Jin M (2011) A Chinese diabetes risk score for screening of undiagnosed diabetes and abnormal glucose tolerance. Diabetes Technol Ther 13:501–507

    Article  Google Scholar 

  54. Mehrabi Y, Sarbakhsh P, Hadaegh F, Khadem-Maboudi A (2010) Prediction of diabetes using logic regression. Iran J Endocrinol Metab 12:16–24

    Google Scholar 

  55. Rathmann W, Kowall B, Heier M, Herder C, Holle R, Thorand B, et al (2010) Prediction models for incident type 2 diabetes mellitus in the older population: KORA S4/F4 cohort study. Diabet Med 27:1116–1123

    Article  CAS  Google Scholar 

  56. Adua E, Russell A, Roberts P, Wang Y, Song M, Wang W (2017) Innovation analysis on Postgenomic biomarkers: glycomics for chronic diseases. OMICS 21(4):183–196

    Article  CAS  Google Scholar 

  57. Wang YX, Adua E, Russell A, Roberts P, Ge S, Zeng Q, Wang W (2016) Glycomics and its application potential in precision medicine. Science 354(6319):36–39

    Google Scholar 

  58. Wang Y, Klarić L, Yu X, Thaqi K, Dong J, Novokmet M, et al (2016) The association between glycosylationof immunoglobulin G and hypertension: a multiple ethnic cross-sectional study. Medicine 95(17):e3379

    Article  CAS  Google Scholar 

  59. Lu JP, Knezevic A, Wang YX, Rudan I, Campbell H, Zou ZK, et al (2011) Screening novel biomarkers for metabolic syndrome by profiling human plasma N-glycans in ChineseHan and Croatian populations. J Proteome Res 10(11):4959–4969

    Article  CAS  Google Scholar 

  60. Adua  E, Memarian E, Russell A, Irbojević-Akmačić I,  Gudelj  I, Jurić J et al (2019) High throughput profiling of whole plasma N-glycans in type II diabetes mellitus patients and healthy individuals: a perspective from a Ghanaian population. Arch Biochem Biophys 661: 10–21

    Article  CAS  Google Scholar 

  61. Golubnitschaja O, Costigliola V (2012) EPMA. General report & recommendations in predictive, preventive and personalised medicine 2012: white paper of the European Association for Predictive, Preventive and Personalised Medicine. EPMA J 3(1):14

    Article  Google Scholar 

  62. Golubnitschaja O, Watson ID, Topic E, Sandberg S, Ferrari M, Costigliola V (2013) Position paper of the EPMA and EFLM: a global vision of the consolidated promotion of an integrative medical approach to advance health care. EPMA J 4(1):12

    Google Scholar 

Download references

Acknowledgments

This book chapter was supported partially by the Joint Project of the Australian National Health and Medical Research Council (NHMRC) and the National Natural Science Foundation of China (NSFC) (NHMRC APP1112767-NSFC 81561128020), and NSFC (NSFC 81773527, 81673247, 81473057, 81370083, 81473063), and the European Commission (EC-H2020-SC1-779238 –PRODEMOS).

The authors acknowledge that parts of the data presented in this chapter have previously been published in our earlier articles [Yan YX et al. J Epideml 2009, 19(6):333–341 l; Wang W, & Yan Y. Clin Transl Med. 2012, 1 (1): 28; Yan YX et al. J Urban Health. 2012;89 (2):329-38; Wang W et al. EPMA J. 2014, 5 (1): 4; Kupaev Vet al. EPMA J. 2016; 7 (1):19; Wang Y et al. J Transl Med. 2016; 14 (1): 291; Adua E et al. EPMA J. 2017, 8 (4): 345-55; Wang Y et al. Sci Rep. 2017, 7 (1): 14975]. This chapter uses the original data but provides a new interpretation based on the innovative paradigm of predictive, preventive and personalised medicine.

The authors thank Miss Belinda Mosdell, Mr Hao Wang and Dr Manshu Song Edith Cowan University, for their English editing.

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Appendix 1: Suboptimal Health Status Questionnaire (SHSQ-25)

Appendix 1: Suboptimal Health Status Questionnaire (SHSQ-25)

The following questions ask some events about your health during the last 3 months.

Answer every question by making the appropriate box with an ‘x’. You may choose from one of the following answers:

1

2

3

4

5

never or almost never

now and then

often

very often

always

How often is it, that you (your)

1

2

3

4

5

1. were exhausted without physical actives significantly increasing.

2. fatigue could not be substantially alleviated by rest.

3. were languid when working.

4. suffered from headaches .

5. suffered from dizziness .

6. eyes were aching and tired.

7. suffered from sore throat.

8. muscles or joints felt stiff.

9. have pains in shoulder/ neck / waist.

10. have heavy feeling in legs when walking.

11. got out of breath while sitting still.

12. suffered from sore throat.

13. were bothered by heart palpitation.

14. got poor appetite.

15. suffered from an upset stomach.

16. suffered from indigestion.

19. got tender fever or cold in-tolerance.

20. had difficulty in falling asleep.

21. had trouble with waking up during night.

22. had trouble with impairment in short memory.

23. could not respond quickly.

24. had difficulty in concentration.

25. were distracted for no reason.

25. were keyed up or jittery.

26. were caught with colds in the past 1 year.

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Wang, W., Tan, X. (2019). Suboptimal Health Status and Cardiovascular Deficits. In: Golubnitschaja, O. (eds) Flammer Syndrome. Advances in Predictive, Preventive and Personalised Medicine, vol 11. Springer, Cham. https://doi.org/10.1007/978-3-030-13550-8_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-13550-8_17

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-13549-2

  • Online ISBN: 978-3-030-13550-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics